Similar efficacy and safety of once-weekly dulaglutide in patients with type 2 diabetes aged >= 65 and < 65 years

Boustani M. A.; Pittman I.; Yu M.; Thieu V. T.; Varnado O. J.; Juneja R.

首页> 外文期刊>Diabetes, obesity & metabolism >Similar efficacy and safety of once-weekly dulaglutide in patients with type 2 diabetes aged >= 65 and < 65 years

【24h】

Similar efficacy and safety of once-weekly dulaglutide in patients with type 2 diabetes aged >= 65 and < 65 years

机译：每周一次dulaglutide在> = 65岁和<65岁的2型糖尿病患者中具有相似的疗效和安全性

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aims: To evaluate the efficacy and safety of dulaglutide 1.5 and 0.75 mg in elderly patients (aged >= 65 years) with type 2 diabetes (T2D) in six phase III clinical trials.

机译：目的：在六项三期临床试验中，评估度拉鲁肽1.5和0.75 mg在2型糖尿病（T2D）的老年患者（年龄≥65岁）中的疗效和安全性。

著录项

来源
《Diabetes, obesity & metabolism》 |2016年第8期|共9页
作者
Boustani M. A.; Pittman I.; Yu M.; Thieu V. T.; Varnado O. J.; Juneja R.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;
关键词
dulaglutide; type 2 diabetes;

机译：度拉鲁肽;2型糖尿病;

相似文献

外文文献
中文文献
专利

1. Similar efficacy and safety of once-weekly dulaglutide in patients with type 2 diabetes aged >= 65 and < 65 years [J] . Boustani M. A., Pittman I., Yu M., Diabetes, obesity & metabolism . 2016,第8期

机译：每周一次dulaglutide在> = 65岁和<65岁的2型糖尿病患者中具有相似的疗效和安全性
2. Safety and efficacy of once-weekly dulaglutide versus sitagliptin after 2years in metformin-treated patients with type 2 diabetes (AWARD-5): a randomized, phase III study [J] . Weinstock R. S., Guerci B., Umpierrez G., Diabetes, obesity & metabolism . 2015,第9期

机译：二甲双胍治疗的2型糖尿病患者（AWARD-5）在2年后每周一次度拉鲁肽与西他列汀的安全性和有效性：一项随机III期研究
3. Safety and efficacy of the dipeptidyl peptidase-4 inhibitor linagliptin in elderly patients with type 2 diabetes: a comprehensive analysis of data from 1331 individuals aged >= 65 years [J] . Schernthaner G., Barnett A. H., Patel S., Diabetes, obesity & metabolism . 2014,第11期

机译：二肽基肽酶-4抑制剂利格列汀在2型糖尿病老年患者中的安全性和有效性：对来自=> 65岁的1331名患者的数据进行的综合分析
4. Loaded Gait Phase of Normalised Comparison between Older Adults Aged 65-80 Years and Adults Aged 25-45 Years [C] . Nibras S. Abbas, Albert K. Chong IEEE Symposium on Computer Applications Industrial Electronics . 2021

机译：65-80岁及25-45岁年龄较大的成人的老年人的正常比较的加载步态阶段
5. Self-management of foot care for patients 65 years of age or older with diabetes. [D] . Frank, Kathryn Irene. 2003

机译：65岁或以上糖尿病患者的足部护理自我管理。
6. Similar efficacy and safety of once‐weekly dulaglutide in patients with type 2 diabetes aged ≥65 and 65 years [O] . M. A. Boustani, I. Pittman IV, M. Yu, -1

机译：每周一次dulaglutide在≥65岁和65岁的2型糖尿病患者中具有相似的疗效和安全性
7. Analysis of efficacy and safety in patients aged 65-75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS). [O] . Neil, HA, DeMicco, DA, Luo, D, 2006

机译：随机分组分析65-75岁患者的疗效和安全性：阿托伐他汀糖尿病合作研究（CARDS）。

Similar efficacy and safety of once-weekly dulaglutide in patients with type 2 diabetes aged >= 65 and < 65 years

摘要

著录项

相似文献

相关主题

期刊订阅